Table 5 Global network effect

AnDDI-Rares: rare diseases with somatic and cognitive developmental abnormalities

1.8e−78

1.44e−77

0.74;1.84

4.47e−45

3.58e−44

0.63;1.64

2711

BRAIN-TEAM: rare diseases with motor or cognitive expression of the central nervous system

1.8e−78

1.44e−77

0.02;1.38

4.47e−45

3.58e−44

0.19;2.35

2711

CARDIOGEN: hereditary cardiac diseases

1.8e−78

1.44e−77

0.32;0.82

4.47e−45

3.58e−44

0.57;1.34

2711

FILFOIE: rare liver disease

1.8e−78

1.44e−77

0.19;1.31

4.47e−45

3.58e−44

0.22;1.40

2711

FILNEMUS: rare neuromuscular diseases

1.8e−78

1.44e−77

0.67;3.01

4.47e−45

3.58e−44

0.72;3.21

2711

FIMARAD: rare dermatological diseases

1.8e−78

1.44e−77

3.18;7.52

4.47e−45

3.58e−44

2.51;5.99

2711

FIMATHO: rare abdomin-thoracic diseases

1.8e−78

1.44e−77

0.31;0.85

4.47e−45

3.58e−44

0.24;0.71

2711

FIRENDO: rare endocrine and gynaecological diseases

1.8e−78

1.44e−77

0.38;1.34

4.47e−45

3.58e−44

0.40;1.39

2711

Fai2r: rare autoimmune and auto-inflammatory diseases

1.8e−78

1.44e−77

0.13;0.72

4.47e−45

3.58e−44

0.10;0.63

2711

G2M: rare hereditary metabolic diseases

1.8e−78

1.44e−77

0.09;0.62

4.47e−45

3.58e−44

0.10;0.66

2711

MHEMO: rare constitutional hemorrhagic diseases

1.8e−78

1.44e−77

0.98;3.88

4.47e−45

3.58e−44

1.01;3.98

2711

Muco CFTR: cystic fibrosis

1.8e−78

1.44e−77

0.00;0.09

4.47e−45

3.58e−44

0.00;0.13

2711

ORKID: rare renal diseases

1.8e−78

1.44e−77

0.10;0.50

4.47e−45

3.58e−44

0.02;0.28

2711

OSCAR: rare bone, calcium and cartilage diseases

1.8e−78

1.44e−77

3.56;7.67

4.47e−45

3.58e−44

1.47;3.30

2711

SENSGENE: rare sensory diseases

1.8e−78

1.44e−77

0;inf

4.47e−45

3.58e−44

0;inf

2711

TETECOU: rare diseases of the head, neck and teeth

1.8e−78

1.44e−77

2.44;6.44

4.47e−45

3.58e−44

2.02;5.37

2711